Source:http://linkedlifedata.com/resource/pubmed/id/12745265
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
2003-5-14
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
1592-8721
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
88
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
482-4
|
| pubmed:dateRevised |
2010-11-18
|
| pubmed:meshHeading |
pubmed-meshheading:12745265-Antibodies, Monoclonal,
pubmed-meshheading:12745265-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:12745265-Antigens, CD20,
pubmed-meshheading:12745265-B-Lymphocytes,
pubmed-meshheading:12745265-Humans,
pubmed-meshheading:12745265-Lymphocyte Depletion,
pubmed-meshheading:12745265-Purpura, Thrombocytopenic, Idiopathic
|
| pubmed:year |
2003
|
| pubmed:articleTitle |
Rituximab: a new therapeutic tool for primary immune thrombocytopenic purpura?
|
| pubmed:publicationType |
Editorial,
Comment
|